• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » TAVI: Direct Flow Medical raises $32m, names 1st CCO

TAVI: Direct Flow Medical raises $32m, names 1st CCO

December 3, 2014 By Brad Perriello

TAVI: Direct Flow Medical raises $32m, names 1st CCO

Direct Flow Medical said today that it landed a $32 million funding round for its replacement heart valve technology and tapped a 25-year medical device veteran, Chris Richardson, to lead its commercialization program.

Santa Rosa, Calif.-based Direct Flow said the funding round includes a $17 million equity investment led by new backers SV Life Sciences and an unnamed strategic investor. The remaining $15 million comes from the 2nd tranche of a $50 million loan from PDL BioPharma, the company said.

Direct Flow won CE Mark approval in the European Union last October for its transcatheter aortic valve implant for patients at extreme risk for open heart surgery, after 1st winning a CE Mark in January 2013. The company won FDA approval for a U.S. pivotal trial in May. 

Today the company said it plans to use the proceeds from its latest round to complete that trial, the Salus study, and "fuel growth of the Direct Flow Medical system outside of the U.S.”

“Direct Flow Medical has developed a true, 2nd-generation transcatheter aortic replacement system that solves many of the clinical issues associated with earlier devices. This platform technology is not only applicable to the treatment of aortic stenosis, but also holds tremendous promise for the treatment of aortic insufficiency and mitral disease," chairman Paul LaViolette, a managing director at SV LifeSciences, said in prepared remarks. "SV Life Sciences is pleased to join the existing group of investors at Direct Flow Medical and provide the capital necessary to build the company’s global business in 2015 and beyond."

Richardson’s pedigree includes a stint as general manager at Abbott Vascular’s structural heart business after Abbott (NYSE:ABT) in 2009 snapped up Evalve and its MitraClip device in a deal worth up to $410 million. He was also an area vice president for Boston Scientific‘s (NYSE:BSX) cardiac rhythm management unit and held positions at Guidant, Heartport and Devices for Vascular Intervention, according to a press release.

"We strive to strengthen our management team at key inflection points in the company’s lifespan, and Chris joins us at a time of rapid growth," Direct Flow president & CEO Bernard Lyons said in a statement. "We are excited to add his expertise and experience to our leadership team as we continue to expand our market share in Europe and focus on enrollment for the Salus pivotal trial in the U.S."

Direct Flow also said it promoted Dan Rose to EMEA vice president & general manager.

Filed Under: Funding Roundup, News Well, Replacement Heart Valves Tagged With: Direct Flow Medical Inc., PDL BioPharma, Personnel Moves, SV Life Sciences, Venture Capital/Private Equity

More recent news

  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
  • Ceryx Medical raises $15M to support bioelectronic pacemaker

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy